Serological detection of Plasmodium vivax malaria using recombinant proteins corresponding to the 19-kDa C-terminal region of the merozoite surface protein-1
about
Platform for Plasmodium vivax vaccine discovery and developmentSerologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax.Detection of Plasmodium falciparum, P. vivax, P. ovale, and P. malariae merozoite surface protein 1-p19 antibodies in human malaria patients and experimentally infected nonhuman primates.Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.Malaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans?Evaluation of the acquired immune responses to Plasmodium vivax VIR variant antigens in individuals living in malaria-endemic areas of BrazilHotspots of Malaria Transmission in the Peruvian Amazon: Rapid Assessment through a Parasitological and Serological Survey.A comparative study of natural immune responses against Plasmodium vivax C-terminal merozoite surface protein-1 (PvMSP-1) and apical membrane antigen-1 (PvAMA-1) in two endemic settingsDuffy Blood Group System and the malaria adaptation process in humansEvaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays.A Novel Malaria Pf/Pv Ab Rapid Diagnostic Test Using a Differential Diagnostic Marker Identified by Network Biology.Assessing malaria transmission in a low endemicity area of north-western Peru.Cellular and humoral immune responses against the Plasmodium vivax MSP-1₁₉ malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil.Allele-specific antibodies to Plasmodium vivax merozoite surface protein-1: prevalence and inverse relationship to haemoglobin levels during infection.Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast.Insights into the naturally acquired immune response to Plasmodium vivax malaria.Asymptomatic infections in blood donors harbouring Plasmodium: an invisible risk detected by molecular and serological tools.Plasmodium vivax Duffy binding protein: baseline antibody responses and parasite polymorphisms in a well-consolidated settlement of the Amazon Region.Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route.Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax.Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.Susceptibility to Plasmodium vivax malaria associated with DARC (Duffy antigen) polymorphisms is influenced by the time of exposure to malariaUtilization of Nucleotide Probes in PCR‐ELISA Procedure for the Quantitative Determination ofPlasmodium FalciparumDNA in Malaria
P2860
Q27021891-3971E9BC-98E6-4342-A043-55E83BEE7E5CQ34091277-F9BE4B7B-4378-4142-9C63-2924737DB092Q34189990-9700FD9A-EFB4-46BA-A676-DC2C72D8EC51Q34606478-29492795-4EA4-42BA-94C1-05EB505A8F2FQ34983659-CC4AC703-26CE-4A6F-B19D-4920539D4DBEQ35113431-8AB8FF24-BF13-4958-AA3A-9EDF42265407Q35769213-1F914246-8D3A-4183-9E6C-1348D70DD50FQ36367968-0911ACA9-0DAF-4F76-B3D4-AFCD4F07D77BQ36464343-6B6AABEC-4DF4-476C-803A-DA2E48C32712Q36974303-A4C9AA72-0450-44BE-8A30-7C26FA38675AQ37012137-84ACF1AA-8D7F-4DDF-A4E8-ADD467B3B99FQ37361179-8805A21A-9126-4315-A35C-DBF4FAD5188DQ37363110-C3809EF4-A29F-44A4-BDFD-14F45F7D8E0DQ37419309-DCF77E70-69B8-4439-893C-C7146E4019E4Q37643896-A3EC3F08-43F9-4926-B4D8-7978682493AEQ38728598-F022F337-187F-4CEC-9166-1AD49E27005DQ39148800-A430FBF9-12B6-4F89-872F-AEEA258B7D90Q44164222-CC58523F-F695-4D74-B116-5EC93BCD3890Q47835607-D4B98E4D-557E-404E-81FB-AA2F6ADBEA9CQ47835642-D3CAA839-561E-446B-BC2F-265D2C40DBF0Q47989426-10A610BA-E757-473C-926F-41CBFCB09F84Q57157434-3260C18B-D81C-4E7E-B95B-8C00A5586122Q58129727-EAF5D3A8-B3EC-4A5F-92B2-1CE31A1327ED
P2860
Serological detection of Plasmodium vivax malaria using recombinant proteins corresponding to the 19-kDa C-terminal region of the merozoite surface protein-1
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Serological detection of Plasm ...... he merozoite surface protein-1
@ast
Serological detection of Plasm ...... he merozoite surface protein-1
@en
Serological detection of Plasm ...... he merozoite surface protein-1
@nl
type
label
Serological detection of Plasm ...... he merozoite surface protein-1
@ast
Serological detection of Plasm ...... he merozoite surface protein-1
@en
Serological detection of Plasm ...... he merozoite surface protein-1
@nl
prefLabel
Serological detection of Plasm ...... he merozoite surface protein-1
@ast
Serological detection of Plasm ...... he merozoite surface protein-1
@en
Serological detection of Plasm ...... he merozoite surface protein-1
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Serological detection of Plasm ...... he merozoite surface protein-1
@en
P2093
Irene S Soares
Maria Helena C Rodrigues
Maristela G Cunha
Mauricio M Rodrigues
Orlando C Ferreira
Ricardo LD Machado
P2860
P2888
P3181
P356
10.1186/1475-2875-2-39
P577
2003-11-14T00:00:00Z
P5875
P6179
1029022720